Mallinckrodt's SpecGx Reports FDA Voted 10-7 To Approve Its Abuse-Deterrent Roxicodone; Committee Voted 12-5 To Label Drug As Abuse-Deterrent By Nasal Route, Voted 10-7 Drug Should Not Be Labeled Abuse-Deterrent By Intravenous Route

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!